Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Top Cited Papers
- 1 March 2018
- journal article
- research article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 18 (3), 318-327
- https://doi.org/10.1016/S1473-3099(17)30753-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal ImplicationsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2016
- Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task ForceValue in Health, 2016
- Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task ForceValue in Health, 2016
- Access to effective antimicrobials: a worldwide challengeThe Lancet, 2015
- The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistanceJournal of Antimicrobial Chemotherapy, 2015
- An Assessment of Antimicrobial Resistant Disease Threats in CanadaPLOS ONE, 2015
- Forgotten Antibiotics: An Inventory in Europe, the United States, Canada, and AustraliaClinical Infectious Diseases, 2012
- Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistanceJournal of Antimicrobial Chemotherapy, 2010
- A new method for scoring additive multi‐attribute value models using pairwise rankings of alternativesJournal of Multi-Criteria Decision Analysis, 2008